902 related articles for article (PubMed ID: 20478252)
1. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Roesch A; Fukunaga-Kalabis M; Schmidt EC; Zabierowski SE; Brafford PA; Vultur A; Basu D; Gimotty P; Vogt T; Herlyn M
Cell; 2010 May; 141(4):583-94. PubMed ID: 20478252
[TBL] [Abstract][Full Text] [Related]
2. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells.
Roesch A; Vultur A; Bogeski I; Wang H; Zimmermann KM; Speicher D; Körbel C; Laschke MW; Gimotty PA; Philipp SE; Krause E; Pätzold S; Villanueva J; Krepler C; Fukunaga-Kalabis M; Hoth M; Bastian BC; Vogt T; Herlyn M
Cancer Cell; 2013 Jun; 23(6):811-25. PubMed ID: 23764003
[TBL] [Abstract][Full Text] [Related]
3. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
Roesch A; Mueller AM; Stempfl T; Moehle C; Landthaler M; Vogt T
Int J Cancer; 2008 Mar; 122(5):1047-57. PubMed ID: 17973255
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
5. Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K; Haraguchi N; Kano Y; Kagawa Y; Konno M; Nishikawa S; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Fukami M; Ishii M; Yamamoto H; Doki Y; Mori M; Ishii H
Int J Oncol; 2013 Apr; 42(4):1212-8. PubMed ID: 23354547
[TBL] [Abstract][Full Text] [Related]
6. A role for the JARID1B stem cell marker for continuous melanoma growth.
Held M; Bosenberg M
Pigment Cell Melanoma Res; 2010 Aug; 23(4):481-3. PubMed ID: 20546534
[No Abstract] [Full Text] [Related]
7. JARID1B expression in human melanoma and benign melanocytic skin lesions.
Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
[TBL] [Abstract][Full Text] [Related]
8. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
9. Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):188-92. PubMed ID: 25789538
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the transcription repressor PLU-1/JARID1B.
Scibetta AG; Santangelo S; Coleman J; Hall D; Chaplin T; Copier J; Catchpole S; Burchell J; Taylor-Papadimitriou J
Mol Cell Biol; 2007 Oct; 27(20):7220-35. PubMed ID: 17709396
[TBL] [Abstract][Full Text] [Related]
11. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
12. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
[TBL] [Abstract][Full Text] [Related]
13. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
Barrett A; Santangelo S; Tan K; Catchpole S; Roberts K; Spencer-Dene B; Hall D; Scibetta A; Burchell J; Verdin E; Freemont P; Taylor-Papadimitriou J
Int J Cancer; 2007 Jul; 121(2):265-75. PubMed ID: 17373667
[TBL] [Abstract][Full Text] [Related]
16. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
[TBL] [Abstract][Full Text] [Related]
17. Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells.
Vogel FCE; Bordag N; Zügner E; Trajkovic-Arsic M; Chauvistré H; Shannan B; Váraljai R; Horn S; Magnes C; Thomas Siveke J; Schadendorf D; Roesch A
J Invest Dermatol; 2019 Dec; 139(12):2506-2516.e10. PubMed ID: 31229500
[TBL] [Abstract][Full Text] [Related]
18. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
19. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
[TBL] [Abstract][Full Text] [Related]
20. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
Xiang Y; Zhu Z; Han G; Ye X; Xu B; Peng Z; Ma Y; Yu Y; Lin H; Chen AP; Chen CD
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19226-31. PubMed ID: 18048344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
